Florian Rothweiler

2.6k citations
56 papers · 2.0k indexed · h-index 23

Impact in

    • Nanoparticle-Based Drug Delivery
  • Oncology top 5%
    • Cancer-related Molecular Pathways
    • Drug Transport and Resistance Mechanisms

Papers in

    • Neuroblastoma Research and Treatments 15
    • Drug Transport and Resistance Mechanisms 10
    • Cancer-related Molecular Pathways 7

Florian Rothweiler

54 papers receiving 1.9k citations

Peers

Florian Rothweiler
Comparison fields: 5 of 107
  • Biomaterials 327
  • Oncology 562
  • Cancer Research 241
  • Molecular Biology 1.1k
  • Neurology 219
Replace Matthew R. Pratt with:
Matthew R. Pratt United States
Wangxiao He China
Jie Tang China
Sander I. van Kasteren Netherlands
Dirk J. Lefeber Netherlands
William Avery United States
Dhaval K. Shah United States
Srikumar M. Raja United States
Serena Mazzucchelli Italy
Xun Sun China
Florian Rothweiler relative to Matthew R. Pratt United States Matthew R. Pratt's profile →
Citations per field
00.5×3.9×
Matthew R. Pratt · 1×
Citations per year

Countries citing papers authored by Florian Rothweiler

Since Specialization
Citations

This map shows the geographic impact of Florian Rothweiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Rothweiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Rothweiler more than expected).

Fields of papers citing papers by Florian Rothweiler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Rothweiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Rothweiler. The network helps show where Florian Rothweiler may publish in the future.

Co-authors

The 25 scholars most cited alongside Florian Rothweiler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Florian Rothweiler Line = papers co-authored together Florian Rothweiler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20239
4 20193
5 201874
6 201718
7 201718
8 20164
9 201571
10 201449
11 201323
12 201210
13 20125
14 201219
15 201215
16 201180
17 201088
18 200983
19 200995
20 2007218

About Florian Rothweiler

Florian Rothweiler is a scholar working on Neurology, Oncology, Molecular Biology, Cancer Research and Immunology and Allergy, having authored 56 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (15 papers), Drug Transport and Resistance Mechanisms (10 papers), Cancer therapeutics and mechanisms (9 papers), Cancer-related Molecular Pathways (7 papers), HIV/AIDS drug development and treatment (5 papers), Bladder and Urothelial Cancer Treatments (5 papers), Protein Degradation and Inhibitors (5 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Biomaterials (327 citations), Oncology (562 citations), Cancer Research (241 citations), Molecular Biology (1.1k citations) and Neurology (219 citations). Florian Rothweiler has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Jindřich Činátl, Martin Michaelis, Klaus Langer, Hans Wilhelm Doerr, J. Kreuter, Jörg Kreuter, Andreas von Deimling, Jaroslav Činátl, Kristoffer Weber and Nadine Löschmann. Their work appears in journals such as Cancers, Oncotarget, Cell Death and Disease, Neoplasia and Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026